PledPharma has restarted recruitment on a clinical trial of mangafodipir in treatment outcomes during angioplasty. The trial had been suspended last year because of a lack of clinical trial material, but the company recently gained approval from the Swedish Medical Products Agency for new CTM supplied by Recipharm. Maria Lundberg, general manager of Recipharm Pharmaceutical Development AB, commented, “We are pleased to contribute to the continuation of this important clinical trial. After being...